Costs and cost-effectiveness of integrated screening for non-communicable diseases in TB contacts.

ABSTRACT:

Background

Integrating non-communicable disease (NCD) screening into TB household contact investigations may identify undiagnosed NCDs and reduce the burden of both conditions. However, evidence on the costs and cost-effectiveness of this approach is limited.

Method

We conducted a cross-sectional study in South Africa to assess patient and provider costs for NCD screening (hypertension, diabetes, chronic kidney disease, dyslipidaemia). Incremental costs per NCD case identified were calculated. Using a decision tree model, we estimated incremental costs per disability-adjusted life year (DALY) averted over 10 years from a healthcare perspective, with cardiovascular disease (CVD) risk estimated using the WHO prediction model.

Results

The incremental cost was USD72.3 per

SUBMITTER: Hamada Y 

PROVIDER: S-EPMC11906026 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature